Danone Put Its Own Brands on Quota to Feed Protein. Dairy Margin Fell to 7.1%

Danone spent the first half of 2026 rationing its own brands. On the results call on 29 July, chief executive Antoine de Saint-Affrique said the non-protein part of the North American range was held back while high-protein yogurt took the factory capacity. In his words, the rest of the portfolio was "under quota".

That is a portfolio strategy set by a production line, and almost nobody reports it that way. The half-year numbers show what it cost.

The quota nobody outside the company saw

Danone's North American problem has been capacity rather than demand. New lines are arriving one at a time. The company is not opening a plant. De Saint-Affrique told analysts the release comes "line by line over the coming quarters", and that the freed capacity will do two jobs: keep feeding protein growth and restart the brands that have been held back. Activia gets the first push in the second half.

The numbers fit the story. North America grew 2.6% like for like in Q2. Volume and mix added 0.7%. Price added 2.0%. Across the wider Americas region, Q2 sales rose 4.3% with volume and mix contributing 0.3% and price 4.0%. Almost all of the growth in Danone's second-biggest region came from price.

The growth engine earns 7.1%

Essential Dairy and Plant-Based is where the protein story lives. It is also the worst-earning business Danone owns.

EDP is 48% of Danone's sales and 26% of its profit. The division made €6,681m of sales in the half and €473m of recurring operating income. Its margin fell 68 basis points to 7.1%. In cash terms, EDP sales rose €49m year on year and its profit fell €42m.

Set that against Specialized Nutrition. That division made €4,730m of sales, 34% of the group, and €1,044m of profit, 56% of the total. Its margin is 22.1%. Danone's slower-growing division earns three times the margin of its fastest-moving one.

Water paid for the margin beat

Group recurring operating margin rose 12 basis points to 13.3%. Waters did most of that work. The division added €53m of profit on €25m of extra reported sales, and its margin jumped 196 basis points to 13.3%. One analyst on the call did the arithmetic out loud and put the whole group beat down to Waters.

Danone's water business now earns almost double what its dairy business earns. That is worth holding in mind while rivals hand their water assets to private equity. Nestlé is putting its waters and premium beverages arm, Perrier and San Pellegrino included, into a joint venture with private equity.

Inflation arrived before the price did

Chief financial officer Juergen Esser gave a plain reason for the dairy margin drop. Inflation started to bite from the second quarter. Price follows with a lag. Danone will raise prices selectively across every region during the third quarter.

The group profit bridge shows the squeeze. Productivity gains added 84 basis points, mostly from overheads. Operations took 54 basis points off, hit by the infant formula recall in EMEA and the first wave of inflation. Reinvestment behind advertising, product and capability cost another 25 basis points.

Cash tells a similar story. Free cash flow came in at €852m, down 27% on last year. Capital spending rose to €414m as Danone builds medical nutrition and high-protein capacity. Stock levels went up by around €250m because the company built safety cover while supply routes through the Middle East stayed unreliable. Esser expects that to unwind.

What has to happen in the second half

Danone held its 2026 guidance: like-for-like sales growth of 3% to 5%, with recurring operating income growing faster than sales. Two things have to land for that. Price has to reach the shelf in EDP during Q3. The new lines have to free enough capacity to restart the brands that spent the half on quota.

The market was not fully convinced. Shares slipped on the day as a slowdown in China pulled attention away from the sales beat. Jefferies said the beat was led by price, and raised its target to €70 with a buy rating.

The lesson travels well beyond Danone. When a plant is full, someone decides every week which brand gets made and which one waits. That person is setting your portfolio strategy. Buying growth in one category by starving another is cheap for two quarters and costly for two years, because the shelf space you give up is bought by somebody else. Operators should price the capacity decision the way they price a launch. Investors have a simpler question for the next results call: which brands are short of capacity, and who decided that.